INVESTMENT AGREEMENTInvestment Agreement • April 9th, 2020 • Aravive, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 9th, 2020 Company Industry JurisdictionTHIS INVESTMENT AGREEMENT (this “Agreement”) is made and entered into at 3:30 p.m. on April 6, 2020, by and among Eshelman Ventures, LLC, a North Carolina limited liability company (the “Investor”), Aravive, Inc., a Delaware corporation (the “Company”), and, solely for purposes of Article IV and Article V, Fredric N. Eshelman, Pharm.D. (the “Incoming Chairman”).
INVESTMENT AGREEMENTInvestment Agreement • August 31st, 2015 • Medicines Co /De • Pharmaceutical preparations • New York
Contract Type FiledAugust 31st, 2015 Company Industry JurisdictionTHIS INVESTMENT AGREEMENT (this “Agreement”) is made and entered into as of this 25th day of August 2015, by and among Eshelman Ventures, LLC, a North Carolina limited liability company (the “Investor”), The Medicines Company, a Delaware corporation (the “Company”), and, solely for purposes of Article IV and Article V, Fredric N. Eshelman, Pharm.D. (the “Incoming Chairman”).